|
|
|
Volumn 53, Issue 6, 1997, Pages 1005-1037
|
|
Fludarabine. An update of its pharmacology and use in the treatment of haematological malignancies
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CYCLOPHOSPHAMIDE;
CYTARABINE;
DOXORUBICIN;
FLUDARABINE;
PREDNISONE;
ACUTE LEUKEMIA;
ALOPECIA;
ANEMIA;
ARTICLE;
BONE MARROW TRANSPLANTATION;
CANCER CHEMOTHERAPY;
CANCER COMBINATION CHEMOTHERAPY;
CLINICAL TRIAL;
DRUG ABSORPTION;
DRUG BLOOD LEVEL;
DRUG EFFICACY;
DRUG TOLERABILITY;
GRANULOCYTOPENIA;
HUMAN;
INFECTION;
INTRAVENOUS DRUG ADMINISTRATION;
LYMPHATIC LEUKEMIA;
LYMPHOMA;
MAJOR CLINICAL STUDY;
META ANALYSIS;
NAUSEA;
NEUROTOXICITY;
NONHODGKIN LYMPHOMA;
PHARMACOKINETICS;
T CELL LYMPHOMA;
THROMBOCYTOPENIA;
VOMITING;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CLINICAL TRIALS;
DRUG SYNERGISM;
DRUG TOLERANCE;
HEMATOLOGIC NEOPLASMS;
HUMANS;
VIDARABINE;
|
|
EID: 0030973344
PISSN: 00126667
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (119)
|
|
References (259)
|
